ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 13 analysts with an average price target of $30.56. This is a potential upside of $19.88 (186.14%) from yesterday's end of day stock price of $10.68.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 182 price targets and 177 ratings on display. The stock rating distribution of ARWR is 84.91% BUY and 15.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.88% with an average time for these price targets to be met of 256.95 days.

Highest price target for ARWR is $80, Lowest price target is $26, average price target is $47.09.

Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 14-Feb-2025. First documented stock forecast 18-Dec-2013.

Currently out of the existing stock ratings of ARWR, 45 are a BUY (84.91%), 8 are a HOLD (15.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$38

$27.32 (255.81%)

$55

1 months 22 days ago
(14-Feb-2025)

8/16 (50%)

$18.89 (98.85%)

135

Buy

$60

$49.32 (461.80%)

$60

1 months 25 days ago
(11-Feb-2025)

4/19 (21.05%)

$41.11 (217.63%)

193

Buy

$42

$31.32 (293.26%)

$42

1 months 25 days ago
(11-Feb-2025)

2/10 (20%)

$23.11 (122.34%)

100

Buy

$80

$69.32 (649.06%)

$80

2 months 13 days ago
(23-Jan-2025)

0/21 (0%)

$58.47 (271.57%)

Buy

$45

$34.32 (321.35%)

$62

4 months 9 days ago
(27-Nov-2024)

22/36 (61.11%)

$18.85 (72.08%)

154

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 256.95 days on average for the stock forecasts to be realized with a an average price target met ratio 66.88

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 10 price targets and 6 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $75.13

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Alethia Young with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?